Perinatal Trials Unit Foundation - Due diligence report
A 360° intelligence report on Perinatal Trials Unit Foundation: trust score, financial health, credit view, compliance, directors, growth an…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Perinatal Trials Unit Foundation — 360° Intelligence Report
Generated from MCA filings & public recordsPerinatal Trials Unit Foundation is assessed as Moderate with a Trust Score of 72/100. Perinatal Trials Unit Foundation is an active private not for profit company incorporated in 2019, operating in the Research & Development sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 28 Oct 2026 from the latest processed filings. Perinatal Trials Unit Foundation snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 1 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2022 - filings overdue.
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RAVI SHANKAR SWAMY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| REKHA SWAMY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 80Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 5 eventsKey Observations
Auto-generated from the data aboveWho Uses This Report
CA · CS · Banker · Investor · VendorVerify Perinatal Trials Unit Foundation before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Perinatal Trials Unit Foundation: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Perinatal Trials Unit Foundation - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 72/100, distress signals and MSME payment-delay disclosures - know whether Perinatal Trials Unit Foundation pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Perinatal Trials Unit Foundation - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Perinatal Trials Unit Foundation an active company?
Perinatal Trials Unit Foundation has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Perinatal Trials Unit Foundation financially healthy?
Perinatal Trials Unit Foundation has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.
Should I do business with Perinatal Trials Unit Foundation?
Its overall Trust Score is 72/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Perinatal Trials Unit Foundation?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Perinatal Trials Unit Foundation have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Perinatal Trials Unit Foundation up to date with its ROC filings?
Last balance sheet is for Mar 2022 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Perinatal Trials Unit Foundation?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.